Company news
Scancell Holdings Plc (LSE:SCLP) news
Scancell Holdings Plc news releases on 6ix. Latest, Jun 3, 2011: Appointment of Broker
Press releases — page 7
Appointment of Broker
June 3, 2011
Re: SCIB1 Clinical Trial Patient Recruitment
January 28, 2011
Re: ImmuneRegen Strategic Collaboration
September 7, 2010
Licence Agreement with Cancer Research Technology
August 10, 2010
Grant of Options
July 14, 2010
Admission to AIM
July 14, 2010
Supply Agreement - Share Options
June 29, 2010
immatics Research Collaboration
June 29, 2010
SCIB1 Phase I Clinical Trial Commences
June 15, 2010
Strategic Collaboration - ImmuneRegen BioSciences
June 4, 2010
Replacement - NIH Licensing Agreeme
May 13, 2010
National Institutes of Health Licensing Agreement
May 11, 2010
Placing
May 10, 2010
CTA Approval for SCIB1
May 5, 2010
Placing of New Ordinary Shares
April 14, 2010
Results of Open Offer
March 29, 2010
Open Offer
March 5, 2010
CTA for SCIB1 melanoma vaccine
February 2, 2010
Appointment of PharmaNet
November 17, 2009
Completion of SCIB1 cGMP Manufacture
November 2, 2009
Agreement with ImmunoVaccine Technologies
August 6, 2009
License of Ichor's TriGrid Electroporation Device
July 16, 2009
Merck Serono Licensing Agreement
July 2, 2009
Change of Advisor
July 1, 2009
Scancell Receives GBP250,000 emda Grant
January 26, 2009
GMP Manufacture Deal With Cobra
January 22, 2009
Half-yearly Report
January 15, 2009
Audited Final Results for the Year Ended 30 Apr...
September 24, 2008